10 reports

  • UCB SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017
  • UCB SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017
  • Healthcare
  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • UCB S.A.
  • UCB Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • UCB Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
  • Healthcare
  • Pharmaceutical
  • United States
  • UCB S.A.
  • NEWBRIDGE PHARMACEUTICALS TARGETS AND PARTNERS (2012 -YTD2016)
  • TARGETS AND PARTNERS
  • Pharmaceutical
  • United Kingdom
  • Company
  • Corporate Finance
  • UCB S.A.
  • Jan 05, 2017: MC10 and UCB Complete Landmark Pharmaceutical / Technology Collaboration Evaluating Patient Monitoring in Parkinson's
  • Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery
  • Pharmaceutical
  • United States
  • Company
  • Company Financials
  • UCB S.A.
  • DIVESTMENTS - DEAL REPORTS
  • Deal rationale
  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • M&A
  • UCB S.A.
  • Prominent Sponsors
  • Clinical Trials by Sponsor Type

AXIAL SPONDYLOARTHRITIS THERAPEUTICS CLINICAL TRIALS, EUROPE, TOP FIVE COUNTRIES (%), 2017* Top Five Countries Contributing to Clinical Trials in Europe Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 tr

  • Monoclonal Antibody
  • Pharmaceutical
  • World
  • Product Initiative
  • UCB S.A.
  • Prominent Sponsors
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* Phase III

KG UCB S. A. ## ## GlaxoSmithKline Plc Arbor Pharmaceuticals, LLC Astellas Pharma Inc.

  • Clinical Trial
  • Neurological Disorder
  • Pharmaceutical
  • World
  • UCB S.A.
  • Business description
  • Deal rationale
  • Healthcare
  • Pharmaceutical
  • United States
  • Corporate Finance
  • UCB S.A.
  • FINANCIAL DEALS ACTIVITY OVERVIEW
  • UCB S.A.: TOP DEALS 2013 - 2017YTD*

He began his career at Bock Pharmaceuticals.

  • Pharmaceutical
  • Therapy
  • Japan
  • Company
  • UCB S.A.
  • UCB S.A., Key Facts
  • Other Locations & Subsidiaries

In 2006, UCB acquired Schwarz Pharma.

  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • UCB S.A.